Thomas Daubon pro - GBmetabo
@thomasdaubon.bsky.social
Cell biologist working on Glioblastoma Metabolism and Spatial Omics
Group leader of GBmetabo - CNRS Research Director : https://www.ibgc.cnrs.fr/la-recherche/glioblastoma-metabolism-gbmetabo/
Enjoy life !
Group leader of GBmetabo - CNRS Research Director : https://www.ibgc.cnrs.fr/la-recherche/glioblastoma-metabolism-gbmetabo/
Enjoy life !
1/5 Excited to share our latest paper published in EMBO Molecular Medicine!🎉 🎉 embopress.org/doi/full/10....
This collaborative work brings together Team1 BRIC_Bordeaux, @ahmadsharanek.bsky.social, Andreas Bikfalvi, Lucie Brisson, Thomas Mathivet and our GBmetabo Team with Audrey Burban
This collaborative work brings together Team1 BRIC_Bordeaux, @ahmadsharanek.bsky.social, Andreas Bikfalvi, Lucie Brisson, Thomas Mathivet and our GBmetabo Team with Audrey Burban
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile | EMBO Molecular Medicine
imageimageIn patient-derived and animal tumour models, mubritinib suppressed glioblastoma stem
cells and tumour growth by targeting mitochondrial respiration. Combination with the
current standard of ...
embopress.org
February 4, 2025 at 8:40 PM
1/5 Excited to share our latest paper published in EMBO Molecular Medicine!🎉 🎉 embopress.org/doi/full/10....
This collaborative work brings together Team1 BRIC_Bordeaux, @ahmadsharanek.bsky.social, Andreas Bikfalvi, Lucie Brisson, Thomas Mathivet and our GBmetabo Team with Audrey Burban
This collaborative work brings together Team1 BRIC_Bordeaux, @ahmadsharanek.bsky.social, Andreas Bikfalvi, Lucie Brisson, Thomas Mathivet and our GBmetabo Team with Audrey Burban